Reuters exclusively reported that India’s pharmaceutical exports this fiscal year are set to grow nearly twice as fast as last year to hit sales of $27 billion, driven by strong U.S. buying, a government-backed trade body told Reuters, despite deaths linked to Indian-made cough syrups.
The post India pharma exports soaring despite cough syrup deaths, trade body says appeared first on Reuters News Agency.